New study aims to predict heart attacks before they happen

NCT ID NCT07353762

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will use data from over 10,000 people to create a risk prediction model for coronary artery disease. Researchers will combine heart imaging scans (like CT angiograms) with blood markers (like cholesterol) to better identify who is at high risk for heart attacks or other major heart events. The model will first be developed using past data, then tested on new participants to see how well it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a more accurate tool for doctors to predict who is at high risk for heart attacks or other heart problems, helping guide earlier or more aggressive treatment.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly help patients. The model may not work as well in real-world settings or different populations, and it will need further validation before it can be used in clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) (E.G., ANGINA, MYOCARDIAL INFARCTION, AND ATHEROSCLEROTIC HEART DISEASE (ASHD)) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Angina Pectoris coronary artery disorder myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••